Shanghai Kaibao Pharmaceutical (300039) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.042x

Based on the latest financial reports, Shanghai Kaibao Pharmaceutical (300039) has a cash flow conversion efficiency ratio of 0.042x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥190.98 Million ≈ $27.95 Million USD) by net assets (CN¥4.55 Billion ≈ $665.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Shanghai Kaibao Pharmaceutical net asset quality index to measure how much of total assets are equity-financed.

Shanghai Kaibao Pharmaceutical - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Shanghai Kaibao Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Shanghai Kaibao Pharmaceutical cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Shanghai Kaibao Pharmaceutical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Kaibao Pharmaceutical ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Empire State Realty Trust Inc
NYSE:ESRT
0.059x
Seegene Inc
KQ:096530
0.037x
Heilongjiang ZBD Pharmaceutical Co Ltd
SHG:603567
0.039x
Lloyds Banking Group PLC
LSE:LLOY
0.141x
Beijing New Space Technology Co Ltd
SHG:605178
0.001x
Dynavox Group
ST:DYVOX
0.161x
Navigator Global Investments Ltd
AU:NGI
0.054x
Shanghai Prisemi Electronics Co Ltd
SHG:688230
0.012x

Annual Cash Flow Conversion Efficiency for Shanghai Kaibao Pharmaceutical (2006–2024)

The table below shows the annual cash flow conversion efficiency of Shanghai Kaibao Pharmaceutical from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Shanghai Kaibao Pharmaceutical worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥4.10 Billion
≈ $600.40 Million
CN¥278.95 Million
≈ $40.82 Million
0.068x -28.35%
2023-12-31 CN¥4.03 Billion
≈ $590.13 Million
CN¥382.66 Million
≈ $56.00 Million
0.095x -5.19%
2022-12-31 CN¥3.76 Billion
≈ $550.36 Million
CN¥376.42 Million
≈ $55.08 Million
0.100x +141.71%
2021-12-31 CN¥3.04 Billion
≈ $445.57 Million
CN¥126.08 Million
≈ $18.45 Million
0.041x -57.41%
2020-12-31 CN¥2.58 Billion
≈ $377.29 Million
CN¥250.65 Million
≈ $36.68 Million
0.097x -25.23%
2019-12-31 CN¥2.57 Billion
≈ $376.00 Million
CN¥334.09 Million
≈ $48.89 Million
0.130x +23.16%
2018-12-31 CN¥2.49 Billion
≈ $363.65 Million
CN¥262.36 Million
≈ $38.39 Million
0.106x +1.62%
2017-12-31 CN¥2.37 Billion
≈ $346.14 Million
CN¥245.76 Million
≈ $35.96 Million
0.104x -27.40%
2016-12-31 CN¥2.20 Billion
≈ $321.97 Million
CN¥314.88 Million
≈ $46.08 Million
0.143x -12.25%
2015-12-31 CN¥2.01 Billion
≈ $293.47 Million
CN¥327.08 Million
≈ $47.86 Million
0.163x +8.85%
2014-12-31 CN¥1.88 Billion
≈ $275.78 Million
CN¥282.38 Million
≈ $41.32 Million
0.150x -10.95%
2013-12-31 CN¥1.61 Billion
≈ $235.02 Million
CN¥270.23 Million
≈ $39.54 Million
0.168x -1.89%
2012-12-31 CN¥1.42 Billion
≈ $207.61 Million
CN¥243.32 Million
≈ $35.61 Million
0.171x +132.79%
2011-12-31 CN¥1.33 Billion
≈ $195.27 Million
CN¥98.31 Million
≈ $14.39 Million
0.074x +360.54%
2010-12-31 CN¥1.24 Billion
≈ $181.01 Million
CN¥19.79 Million
≈ $2.90 Million
0.016x -65.23%
2009-12-31 CN¥1.15 Billion
≈ $167.72 Million
CN¥52.74 Million
≈ $7.72 Million
0.046x -68.76%
2008-12-31 CN¥126.92 Million
≈ $18.57 Million
CN¥18.70 Million
≈ $2.74 Million
0.147x -51.29%
2007-12-31 CN¥76.96 Million
≈ $11.26 Million
CN¥23.27 Million
≈ $3.41 Million
0.302x -42.84%
2006-12-31 CN¥37.24 Million
≈ $5.45 Million
CN¥19.70 Million
≈ $2.88 Million
0.529x --

About Shanghai Kaibao Pharmaceutical

SHE:300039 China Drug Manufacturers - Specialty & Generic
Market Cap
$834.19 Million
CN¥5.70 Billion CNY
Market Cap Rank
#9602 Global
#2420 in China
Share Price
CN¥5.45
Change (1 day)
-0.91%
52-Week Range
CN¥4.18 - CN¥6.96
All Time High
CN¥12.44
About

Shanghai Kaibao Pharmaceutical CO.,Ltd engages in the research, development, production, and sale of modern traditional Chinese medicines primarily in China. The company offers heat-clearing and detoxifying products, such as Tanreqing Injection for wind-heat in the lungs with phlegm-heat obstructing the lungs, early-stage pneumonia, acute bronchitis, acute exacerbations of chronic bronchitis, and… Read more